Request for Information-Revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of Comment Period, 49544 [2019-20419]

Download as PDF 49544 Federal Register / Vol. 84, No. 183 / Friday, September 20, 2019 / Notices required to accomplish an agency function, the applicable Privacy Act Federal Acquisition Regulation (FAR) clauses are inserted in solicitations and contracts. Technical Safeguards: Controls executed by the computer system are employed to minimize the possibility of unauthorized access, use, or dissemination of the data in the system. They include, but are not limited to, user identification, password protection, firewalls, virtual private network, encryption, intrusion detection system, common access cards, smart cards and public key infrastructure. Physical Safeguards: Controls to secure the data and protect paper and electronic records, buildings, and related infrastructure against threats associated with their physical environment include, but are not limited to, the use of the HHS Employee ID and/or badge number and NIH key cards, security guards, cipher locks, and closed-circuit TV. Paper records are secured under conditions that require at least two locks to access, such as in locked file cabinets that are contained in locked offices or facilities. Electronic media are kept on secure servers or computer systems. RECORD ACCESS PROCEDURES: Certain material is exempt from access; however, consideration will be given to all access requests addressed to the System Manager. To request access to a record about you, write to the System Manager identified above, and provide the information described under ‘‘Notification Procedure’’. Individuals may also request an accounting of disclosures that have been made of their records, if any. khammond on DSKJM1Z7X2PROD with NOTICES CONTESTING RECORD PROCEDURES: Certain material is exempt from amendment; however, consideration will be given to all amendment requests addressed to the System Manager. To contest information in a record about you, write to the System Manager identified above, reasonably identify the record and specify the information being contested, state the corrective action sought and the reason(s) for requesting the correction, and provide supporting information. The right to contest records is limited to information that is factually inaccurate, incomplete, irrelevant, or untimely (obsolete). NOTIFICATION PROCEDURES: Certain material is exempt from notification; however, consideration will be given to all notification requests addressed to the System Manager. Any individual who wants to know whether VerDate Sep<11>2014 17:13 Sep 19, 2019 Jkt 247001 this system of records contains a record about him or her must make a written request to the System Manager identified above. The requester should provide either a notarization of the request or a written certification that the requester is who he or she claims to be and understands that the knowing and willful request of a record pertaining to an individual under false pretenses is a criminal offense under the Privacy Act, subject to a five thousand dollar fine. The request should include the requester’s full name and address, and should also include the following information, if known: The approximate date(s) the information was collected, the type(s) of information collected, and the office(s) or official(s) responsible for the collection of information. EXEMPTIONS PROMULGATED FOR THE SYSTEM: Pursuant to 5 U.S.C. 552a(k)(5), the following subset of records in this system of records qualifies as investigatory material compiled solely for the purpose of determining suitability, eligibility, or qualifications for federal contracts, and is exempt from the Privacy Act requirements pertaining to providing an accounting of disclosures, access and amendment, notification, and agency procedures and rules (5 U.S.C. 552a (c)(3), and (d)(1)– (4)): Material that would inappropriately reveal the identities of referees who provide letters of recommendation and peer reviewers who provide written evaluative input and recommendations to NIH about particular funding applications under an express promise by the government that their identities in association with the written work products they authored and provided to the government will be kept confidential; this includes only material that would reveal a particular referee or peer reviewer as the author of a specific work product (e.g., reference or recommendation letters, reviewer critiques, preliminary or final individual overall impact/priority scores, and/or assignment of peer reviewers to an application and other evaluative materials and data compiled by NIH/OER); it includes not only an author’s name but any content that could enable the author to be identified from context. To the extent that records in System No. 09–25–0225 are retrieved by personal identifiers for individuals other than referees and peer reviewers (for example, individual funding applicants, and other individuals who are the subject of assessment or evaluation), the exemptions enable the agency to prevent, when appropriate, PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 those individual record subjects from having access to, and other rights under the Privacy Act with respect to, the above-described confidential sourceidentifying material in the records. HISTORY: 81 FR 88690 (Dec. 8, 2016), 83 FR 6591 (Feb.14, 2018). [FR Doc. 2019–20423 Filed 9–19–19; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH OF HUMAN SERVICES Request for Information—Revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of Comment Period Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice; extension of comment period. AGENCY: The Office of the Assistant Secretary for Health published a document in the Federal Register of August 27, 2019, requesting public comment related to revisions to the PHS Guideline for Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) Through Organ Transplantation. Due to numerous requests of an extension to the public comment period, this document is announcing an extension. DATES: To be assured consideration, comments must be received at the address provided below no later than 5:00 p.m. ET on October 10, 2019. FOR FURTHER INFORMATION CONTACT: Mr. James Berger, (202) 795–7608; ACBTSA@hhs.gov. SUMMARY: Dated: September 17, 2019. James J. Berger, Senior Advisor for Blood and Tissue Policy, Office of the Assistant Secretary for Health. [FR Doc. 2019–20419 Filed 9–19–19; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Clinical Aging E:\FR\FM\20SEN1.SGM 20SEN1

Agencies

Department of Health of Human Services

[Federal Register Volume 84, Number 183 (Friday, September 20, 2019)]
[Notices]
[Page 49544]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20419]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH OF HUMAN SERVICES


Request for Information--Revisions to the PHS Guideline for 
Reducing Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), 
and Hepatitis C Virus (HCV) Through Organ Transplantation; Extension of 
Comment Period

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The Office of the Assistant Secretary for Health published a 
document in the Federal Register of August 27, 2019, requesting public 
comment related to revisions to the PHS Guideline for Reducing Human 
Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), and Hepatitis C 
Virus (HCV) Through Organ Transplantation. Due to numerous requests of 
an extension to the public comment period, this document is announcing 
an extension.

DATES: To be assured consideration, comments must be received at the 
address provided below no later than 5:00 p.m. ET on October 10, 2019.

FOR FURTHER INFORMATION CONTACT: Mr. James Berger, (202) 795-7608; 
[email protected].

    Dated: September 17, 2019.
James J. Berger,
Senior Advisor for Blood and Tissue Policy, Office of the Assistant 
Secretary for Health.
[FR Doc. 2019-20419 Filed 9-19-19; 8:45 am]
 BILLING CODE 4150-28-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.